The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...
Inquirer on MSN10d
Ketamine a lifeline for severe depression patients in SingaporeKetamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...
Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.
Senior consultant psychiatrist Victor Kwok, who has offered Spravato treatment since December 2020, said: “It’s very fast-acting. Some get better within two sessions.” More than 15 patients ...
All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...
Boing Boing on MSN6d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced two ...
In response to the devastating wildfires affecting communities across California, Bespoke Treatment, a leading provider of innovative mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback